Cen Biotech Inc Asset Turnover Ratio (CENB), as of third quarter 2022, current and historic results, rankings and more - CSIMarket
CSIMarket
 


Cen Biotech Inc  (CENB)
 

Cen Biotech Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Cen Biotech Inc's asset turnover ratio, the ratio that measures the ability of Cen Biotech Inc's assets to generate revenue, sequentially decreased to 0.22 in the third quarter (Sep 30 2022), which does not come as a surprise, as the Cen Biotech Inc continue to experience difficult business climate.

Within sector 74 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Third Quarter 2022 compared to the preceding quarter from 0 to 1588.

Asset Turnover Ratio Definition



CENB Asset Turnover Ratio (Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Asset Change 19.69 % 39.79 % 32.11 % -18.41 % -19.46 %
Y / Y Revenue Change -50.07 % - - - -
Asset Turnover Ratio (TTM) 0.22 0.26 0.18 0.13 0.05
CENB's Total Ranking # 1588 # 0 # # #
Seq. Asset Change -16.22 % -1.45 % 47.6 % -1.78 % -2.16 %
Seq. Revenue Change -74.95 % 59.42 % -4.06 % 30.32 % -



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 75
Healthcare Sector # 166
Overall Market # 1588

Asset Turnover Ratio Statistics
High Average Low
8.97 8.61 8.26
(Sep 30 2022)   (Jun 30 2022)







Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2022, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2022 Assets at quarter ending Sep 30 2022
Iradimed Corporation  0.65 $ 50.312  Millions$ 77.636  Millions
Luna Innovations Inc  0.65 $ 90.744  Millions$ 140.508  Millions
Clearside Biomedical Inc   0.65 $ 26.684  Millions$ 41.348  Millions
Myovant Sciences Ltd   0.64 $ 333.323  Millions$ 517.102  Millions
Abiomed Inc   0.64 $ 1,074.096  Millions$ 1,666.613  Millions
Kaya Holdings Inc   0.64 $ 0.756  Millions$ 1.174  Millions
Marpai Inc  0.64 $ 22.609  Millions$ 35.211  Millions
Incyte Corporation  0.64 $ 3,330.788  Millions$ 5,204.206  Millions
Penumbra Inc  0.64 $ 829.928  Millions$ 1,298.831  Millions
Rigel Pharmaceuticals Inc  0.64 $ 89.373  Millions$ 140.003  Millions
Koru Medical Systems Inc   0.64 $ 27.042  Millions$ 42.462  Millions
Radnet Inc   0.64 $ 1,382.155  Millions$ 2,171.970  Millions
Evolus Inc   0.63 $ 139.627  Millions$ 220.446  Millions
Intercept Pharmaceuticals inc   0.63 $ 330.331  Millions$ 522.095  Millions
Sangui Biotech International Inc  0.63 $ 0.092  Millions$ 0.145  Millions
Edwards Lifesciences Corporation  0.63 $ 5,363.800  Millions$ 8,496.450  Millions
Kiniksa Pharmaceuticals International Plc  0.62 $ 177.041  Millions$ 283.574  Millions
Msa Safety Inc  0.62 $ 1,492.847  Millions$ 2,401.977  Millions
Vivos Therapeutics Inc   0.62 $ 16.468  Millions$ 26.505  Millions
Eli Lilly And Company  0.61 $ 29,239.500  Millions$ 47,562.600  Millions
Tela Bio Inc   0.61 $ 38.075  Millions$ 62.199  Millions
Qhslab Inc   0.61 $ 1.305  Millions$ 2.144  Millions
Abbott Laboratories  0.61 $ 45,030.000  Millions$ 74,051.500  Millions
Seaspine Holdings Corporation  0.61 $ 229.747  Millions$ 379.343  Millions
Lensar Inc   0.61 $ 36.348  Millions$ 60.066  Millions
Sharecare Inc   0.60 $ 438.281  Millions$ 726.544  Millions
Aytu Biopharma Inc  0.60 $ 102.427  Millions$ 170.068  Millions
Therapeuticsmd Inc   0.60 $ 87.489  Millions$ 145.741  Millions
Talkspace Inc   0.60 $ 118.498  Millions$ 198.029  Millions
Clearmind Medicine Inc  0.60 $ 0.493  Millions$ 0.826  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.